Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double Blind, Placebo-controlled, Dose Response Study of Intraspinal Gabapentin (MDT2004) in Subjects With Chronic, Intractable Pain.

NCT00414466 is registered in ClinicalTrials.gov with MedtronicNeuro as lead sponsor.

NCT NCT00414466
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00414466 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double Blind, Placebo-controlled, Dose Response Study of Intraspinal Gabapentin (MDT2004) in Subjects With Chronic, Intractable Pain.
Lead sponsor
MedtronicNeuro
Phase
Phase 2
Overall status
Terminated
Start date
December 31, 2006
Completion date
August 31, 2010
Enrollment
254 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

chronic intractable pain